Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
5.01
+0.06 (1.21%)
At close: Nov 20, 2024, 4:00 PM
4.940
-0.070 (-1.40%)
Pre-market: Nov 21, 2024, 4:04 AM EST
Rezolute Market Cap
Rezolute has a market cap or net worth of $280.20 million as of November 21, 2024. Its market cap has increased by 674.03% in one year.
Market Cap
280.20M
Enterprise Value
164.46M
1-Year Change
674.03%
Ranking
Category
Stock Price
$5.01
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $280.20M, an increase of 67.78%. That is a compound annual growth rate of 13.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 290.30M | 638.68% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 287.88M |
| Vanda Pharmaceuticals | 286.88M |
| uniQure | 283.69M |
| Nautilus Biotechnology | 281.26M |
| Accolade | 281.07M |
| Artiva Biotherapeutics | 274.47M |
| Mersana Therapeutics | 274.24M |
| NeuroPace | 274.01M |